International Medical Research Frontier

Cervical cancer is one of the common gynecological malignant tumors in China. The main treat- ment for intermediate and advanced cervical cancer is radiotherapy. Improving radiotherapy sensitivity is the key to improve the prognosis of patients with cervical cancer. In recent years, miRNA has been found to play an important role in the regulation of radiosensitivity in cervical cancer. In this paper, we reviewed the role and mechanism of miRNA in regulating radiotherapy sensitivity of cervical cancer, emphasized the clinical prospect of miRNA in tumor diagnosis and treatment in the future, and further expounded the significance of exploring new mechanisms and discovering new targets for improving radiotherapy efficacy.

Cervical cancer; Micrornas; Radiosensitivity; Molecular marker